| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/05/2006 | US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections |
| 12/05/2006 | US7144738 Materials for enhancing staining of biopolymers in matrices |
| 12/05/2006 | US7144731 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 12/05/2006 | US7144728 Method of inducing anergic T helper cells |
| 12/05/2006 | US7144723 Model gram-positive bacteria which have sodium requirement for production, discovery and testing of immunomodulators, agrichemicals, enzyme inhibitors, viricides, bactericides, fungicides and anticarcinogenic agents; drug screening |
| 12/05/2006 | US7144720 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 12/05/2006 | US7144714 recombinantly coexpressing a Dicer protein with an R2D2 protein to form a complex; contacting complex with a double-stranded RNA wherein the complex cleaves the dsRNA into siRNA; Drosophila R2D2 protein; Drosophila Dicer-2 protein; may be coexpressed in insect cells using a baculovirus expression system |
| 12/05/2006 | US7144711 Nucleotide sequences coding G protein coupled-receptor independent activators and inhibitors of the pheromone pathway for treating and preventing cell proliferative and atherosclerotic disorders |
| 12/05/2006 | US7144709 Diagnostics based on tetrazolium compounds |
| 12/05/2006 | US7144707 Determination of risk and treatment of complications of prematurity |
| 12/05/2006 | US7144704 Incubating mammalian cell expressing multidrug resistance gene or P-glycoprotein with immunological reagent specific for a biochemical conformation; evaluating binding; drug screening for anticarcinogenic agents |
| 12/05/2006 | US7144703 Composition |
| 12/05/2006 | US7144702 Comprises conducting PCR using a member selected from the group consisting of two primers that hybridize under stringent conditions to a nucleic acid molecule having a common nucleotide sequence for all species in the target plant genus |
| 12/05/2006 | US7144701 Screening numerous CpG dinucleotide rich fragments affixed on a screening array; positive hybridization signals indicate the presence of methylated sites. |
| 12/05/2006 | US7144700 Removing photolabile group from nucleic acid, nucleotide, or nucleoside in presence of 9,10-dimethylanthrancene sensitizer; deblocking and deprotective removal of (( alpha -methyl-2-nitropiperonyl)-oxy)carbonyl (MeNPOC), ((Phenacyl)-oxy)carbonyl (PAOC), and O-(9-phenylxanthen-9-yl) (PIXYL) groups |
| 12/05/2006 | US7144699 Iterative resequencing |
| 12/05/2006 | US7144698 Postweaning multisystemic wasting syndrome virus from pigs |
| 12/05/2006 | US7144697 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 12/05/2006 | US7144696 Use of azetidinone compounds |
| 12/05/2006 | US7144616 Microfabricated elastomeric valve and pump systems |
| 12/05/2006 | US7144496 Biological fluid analysis device |
| 12/05/2006 | US7144119 System and method for programmable illumination pattern generation |
| 12/05/2006 | CA2246802C A human cytomegalovirus combined antigen and its use |
| 12/05/2006 | CA2215067C Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 11/30/2006 | WO2006128192A2 Use of free circulating dna for diagnosis, prognosis, and treatment of cancer |
| 11/30/2006 | WO2006128138A2 Biodetection by nucleic acid-templated chemistry |
| 11/30/2006 | WO2006128124A2 Total awareness surveillance system |
| 11/30/2006 | WO2006128117A2 Polymorphisms in mitochondrial transcription factor a (tfam) gene and their associations with measures of marbling and subcutaneous fat dept in beef cattle |
| 11/30/2006 | WO2006128116A2 Polymorphisms in fatty acid binding protein 4(fabp4) gene and their associations with measures of marbling and subcutaneous fat depth in beef cattle |
| 11/30/2006 | WO2006128098A2 Cytometric system including nucleic acid sequence amplification, and method |
| 11/30/2006 | WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| 11/30/2006 | WO2006128010A2 Quantification of nucleic acids and proteins using oligonucleotide mass tags |
| 11/30/2006 | WO2006127913A2 Modulation of lmw-ptpase expression |
| 11/30/2006 | WO2006127704A2 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia |
| 11/30/2006 | WO2006127609A2 Polymorphism in the macrophage migration inhibitory factor (mif) gene as marker for prostate cancer |
| 11/30/2006 | WO2006127607A2 Pi3k pathway mutations in cancer |
| 11/30/2006 | WO2006127562A2 Wireless power transmission system |
| 11/30/2006 | WO2006127537A2 Thyroid fine needle aspiration molecular assay |
| 11/30/2006 | WO2006127507A2 Compounds and methods for labeling oligonucleotides |
| 11/30/2006 | WO2006127420A1 Methods for improving fidelity in a nucleic acid synthesis reaction |
| 11/30/2006 | WO2006127294A2 Methods for diagnosis or prognosis of late age onset disease |
| 11/30/2006 | WO2006127197A2 Mechanism to support transparent roaming in heterogeneous service discovery systems |
| 11/30/2006 | WO2006127023A2 Epoxy enhanced polymer membrane to increase durability of biosensors |
| 11/30/2006 | WO2006126865A1 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 11/30/2006 | WO2006126706A1 Prophylactic/therapeutic agent for psychotic disorder such as bipolar mood disorder and schizophrenia, screening method for the same, and method for determination of risk for the development of the disease |
| 11/30/2006 | WO2006126618A1 Method of determining gene polymorphism for judgment of disease risk level, method of judging disease risk level and array for relevant judgment |
| 11/30/2006 | WO2006126574A1 Method for induction of es cell differentiation |
| 11/30/2006 | WO2006126570A1 Method for simultaneous analysis of multiple bioilogical reactions or changes in in vivo conditions |
| 11/30/2006 | WO2006126040A1 Bacterial and bacterial associated mirnas and uses thereof |
| 11/30/2006 | WO2006125855A1 Correction method and measurement device for anti-stokes photoluminescence measurement |
| 11/30/2006 | WO2006125830A2 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 11/30/2006 | WO2006125827A1 Serine proteases with altered sensitivity to activity-modulating substances |
| 11/30/2006 | WO2006125808A1 Method for analysis of de-novo transcribed rna in vivo |
| 11/30/2006 | WO2006125513A1 Genetic association of polymorphisms in the atf6-alpha gene with insulin resistance phenotypes |
| 11/30/2006 | WO2006125493A2 USE OF NOVEL HNF4α TARGET GENES AND THEIR GENE PRODUCTS |
| 11/30/2006 | WO2006125458A1 Parallel sequencing of transformed nucleic acids in encapsulated cells |
| 11/30/2006 | WO2006125301A1 Diagnostic applications of microarrays in organ transplantation |
| 11/30/2006 | WO2006125267A1 Isothermal strand displacement amplification using primers containing a non-regular base |
| 11/30/2006 | WO2006117596A8 Nucleic acid probes and nucleic acid analog probes |
| 11/30/2006 | WO2006109193A3 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof |
| 11/30/2006 | WO2006102111A3 Biomarker for sensitivity to mtor inhibitor therapy in kidney cancer |
| 11/30/2006 | WO2006096345A3 Coagulation and fibrinolytic cascades modulator |
| 11/30/2006 | WO2006074878A3 Method and kit for detecting mycobacterium avium subsp. paratuberculosis (map) in samples of faeces, body tissues or milk |
| 11/30/2006 | WO2006063717A3 Polymerase-independent analysis of the sequence of polynucleotides |
| 11/30/2006 | WO2006058031A3 Microarray quality control |
| 11/30/2006 | WO2006037485A3 Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy |
| 11/30/2006 | WO2006014490A3 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 11/30/2006 | WO2006007180A3 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia |
| 11/30/2006 | WO2005116256A3 Device for extracting biological molecules from tissue specimens |
| 11/30/2006 | WO2005113811A3 Combinatorial selection of phosphorothioate aptamers for tgf-beta |
| 11/30/2006 | WO2005100989A3 Hepatotoxicity molecular models |
| 11/30/2006 | WO2005089287A3 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 11/30/2006 | WO2005040343A3 Improved apparatus and method for identification of biomolecules, in particular nucleic acid sequences, proteins, and antigens and antibodies |
| 11/30/2006 | WO2004061124A3 Compositions, methods, and systems for inferring bovine breed |
| 11/30/2006 | WO2004047728A3 Compositions and methods for the treatment of immune related diseases |
| 11/30/2006 | WO2003016477A3 Insect or83b odorant receptor |
| 11/30/2006 | US20060272056 Plant 1-deoxy-D-xylulose 5-phosphate synthase |
| 11/30/2006 | US20060272042 designated J-101 and having representative seed deposited with American Type Culture Collection (ATCC) with Accession No. PTA-4814; |
| 11/30/2006 | US20060272039 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 11/30/2006 | US20060272035 Screening method with the use of TBK1 knockout mouse |
| 11/30/2006 | US20060271309 Method of diagnosis of cancer based on gene expression profiles in cells |
| 11/30/2006 | US20060270841 Assays to monitor amyloid precursor protein processing |
| 11/30/2006 | US20060270840 Pentopyranosyl nucleic acid conjugates |
| 11/30/2006 | US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha |
| 11/30/2006 | US20060270624 Gapped 2' modified oligonucleotides |
| 11/30/2006 | US20060270623 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA) |
| 11/30/2006 | US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs |
| 11/30/2006 | US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 11/30/2006 | US20060270604 Pharmaceutical preparations of Fn3 polypeptides for human treatments |
| 11/30/2006 | US20060270595 Nucleic acids encoding compositions of THAP-family chemokine binding domains |
| 11/30/2006 | US20060270062 Mass spectrometric immunoassay |
| 11/30/2006 | US20060270029 Automatable artificial immune system (AIS) |
| 11/30/2006 | US20060270025 Microfermentor device and cell based screening |
| 11/30/2006 | US20060270019 Method for producing lactic acid bacterium culture containing bacteriocin and a method for preserving food products for by using it |
| 11/30/2006 | US20060270010 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 11/30/2006 | US20060269984 Method for identifying Listeria monocytogenes and culture medium |
| 11/30/2006 | US20060269982 Colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)- beta -D-glucan; incubating sample with hemolymph from a Lepidopteran insect, a phenoloxidase substrate that generates a reaction product, and 3-methyl-2-benzothiazolinone hydrazone then detecting color |
| 11/30/2006 | US20060269981 Diagnostic kit for hirschsprung disease (Congenital Megacolon) |
| 11/30/2006 | US20060269980 Complete chemical and enzymatic treatment of phosphorylated and glycosylated proteins on protein chip arrays |
| 11/30/2006 | US20060269979 High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases |